Dietary palmitic acid inhibits colorectal cancer progression through enhancing bisecting GlcNAc

Lei Lei1, Juan Tang1, Yuejiao Lv1

  • 1Key Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, Xi'an, China.

JCI Insight
|March 23, 2026
PubMed

Insights

Dietary palmitic acid (PA) suppresses colorectal cancer (CRC) by increasing bisecting N-acetylglucosamine (GlcNAc) levels. This modification on desmoglein 2 (DSG2) inhibits cancer progression via the EGFR/AKT pathway.

Area of Science:

  • Oncology
  • Glycobiology
  • Nutritional Science

Background:

  • Aberrant glycosylation, particularly bisecting N-acetylglucosamine (GlcNAc), is implicated in colorectal cancer (CRC) development.
  • The enzyme MGAT3 catalyzes bisecting GlcNAc, but its role and regulation in CRC are not fully understood.
  • The influence of dietary fatty acids, like palmitic acid (PA), on glycosylation in CRC remains largely unexplored.

Purpose of the Study:

  • To investigate the role of bisecting GlcNAc and MGAT3 in colorectal cancer (CRC).
  • To determine the impact of dietary palmitic acid (PA) on CRC progression and glycosylation.
  • To elucidate the molecular mechanisms linking dietary PA, glycosylation, and CRC carcinogenesis.

Main Methods:

  • Analysis of bisecting GlcNAc and MGAT3 levels in human CRC tissues and cell lines.
  • Assessment of cell proliferation, migration, invasion, and apoptosis in CRC cells with altered bisecting GlcNAc levels.
  • Utilizing azoxymethane/dextran sodium sulfate-induced CRC mouse models, including Mgat3-deficient mice, to evaluate the effects of a PA-rich diet.
  • Intact glycopeptide analysis to identify PA-modified glycoproteins, followed by investigation of the EGFR/AKT signaling pathway.

Main Results:

  • Decreased bisecting GlcNAc and MGAT3 levels were observed in human CRC tissues.
  • Reduced bisecting GlcNAc in CRC cells correlated with increased proliferation, migration, invasion, and decreased apoptosis.
  • A PA-rich diet suppressed CRC development in mice by upregulating bisecting GlcNAc, an effect dependent on MGAT3.
  • Palmitic acid (PA) was found to enhance bisecting GlcNAc modification on desmoglein 2 (DSG2), which inhibits CRC carcinogenesis via the EGFR/AKT pathway.

Conclusions:

  • Dietary palmitic acid (PA) exerts a protective effect against colorectal cancer (CRC) carcinogenesis.
  • This suppression is mediated by PA-induced enhancement of bisecting N-acetylglucosamine (GlcNAc) modification on desmoglein 2 (DSG2).
  • The findings establish a direct mechanistic link between dietary fatty acids and CRC suppression through specific glycosylation patterns.